<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT04401033</url>
  </required_header>
  <id_info>
    <org_study_id>003</org_study_id>
    <nct_id>NCT04401033</nct_id>
  </id_info>
  <brief_title>Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study)</brief_title>
  <acronym>DECORE</acronym>
  <official_title>Prospective Observational Study Evaluating the Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopic Procedures (DECORE Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital del Río Hortega</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital del Río Hortega</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study to compare the proportion of patients who develop SARS-CoV-2 disease in&#xD;
      3 groups: patients undergoing a abdominal ultrasound examination in a Specialty Center,&#xD;
      patients undergoing endoscopic procedure in a third level hospital with CoronaVirus Disease&#xD;
      (COVID-19) hospitalization plants and patients who make a telephonic visit (do not go to the&#xD;
      hospital) in the digestive system service.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will undergo a telephonic interview 48-96h before the procedure where will ask about&#xD;
      the presence of symptoms suggestive of SARS-CoV-2 infection. Optionally, they will also be&#xD;
      carried out a scan (PCR) to detect infection 48-96h before procedure, withdrawing from the&#xD;
      study patients with positive PCR or infection suspected by clinical data according to the&#xD;
      questionnaire, after evaluating the responses to the questionnaire by one of the members of&#xD;
      the research team.&#xD;
&#xD;
      Endoscopic examinations will be carried out according to the recommendations of the Spanish&#xD;
      Society for Digestive Endoscopy (SEED). The patient will perform a hand wash with solution&#xD;
      hydroalcoholic before entering the endoscopy room, and you will be placed a surgical mask and&#xD;
      gloves. Staff close to the patient will carry FFP2 mask, exceptionally surgical mask, gown&#xD;
      (waterproof in high-risk examinations as established in the SEED guidelines), hat, nitrile&#xD;
      gloves and face shield or safety glasses (reusable) and shim covers. The examinations will be&#xD;
      carried out using sedation guided by endoscopist according to current clinical guidelines.&#xD;
&#xD;
      Ultrasonographic examinations (US) will be carried out according to clinical guideline. The&#xD;
      examinator will wear a filtering face pieces 2 (FFP2) mask, exceptionally surgical mask,&#xD;
      gown, cap, nitrile gloves and face shield or goggles safety (reusable) and shoe covers. The&#xD;
      gel bottle, the transducer and the gurney will be washed before each US with low level&#xD;
      disinfectant.&#xD;
&#xD;
      Patients who meet the inclusion criteria and do not have any exclusion criteria will be&#xD;
      invited to participate in the study. The patients who agree to participate will complete the&#xD;
      informed consent according to the law 41/2002 of patient autonomy without for that reason&#xD;
      alter the relationship with your doctor or cause any harm to your treatment. The monitoring&#xD;
      period will have a maximum duration of 17 days. It will consist of a telephone control&#xD;
      through a pre-established checklist. In case of any positive answer to the questionnaire, it&#xD;
      will be completed the study through the consultation of the investigators by means of a&#xD;
      polymerase chain reaction (PCR).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 11, 2020</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Months</target_duration>
  <primary_outcome>
    <measure>SARS-CoV-2 infection in patients</measure>
    <time_frame>may-june 2020</time_frame>
    <description>Proportion of patients who develop SARS-CoV-2 infection in 3 groups: patients undergoing an abdominal ultrasound examination in a Specialty Center, patients undergoing an endoscopic examination in a third-level hospital with hospitalization facilities COVID-19 and patients who make a non-face-to-face consultation (do not go to the hospital) in the digestive system service</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SARS-CoV-2 infection in HCW</measure>
    <time_frame>may-june 2020</time_frame>
    <description>Number of Health Care Workers (HCW) who develop SARS-CoV-2 infection in endoscopy service in this period</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">450</enrollment>
  <condition>SARS-CoV 2</condition>
  <condition>COVID</condition>
  <arm_group>
    <arm_group_label>Endoscopic cohort</arm_group_label>
    <description>Endoscopic examinations: They will be carried out according to the recommendations of the Spanish society for digestive endoscopy (SEED). In summary, the patient will perform a hand wash with hydroalcoholic solution before entering the endoscopy room, and will put on a surgical mask and gloves. Personnel close to the patient will wear an FFP2 mask, exceptionally a surgical mask, a gown (waterproof in high-risk examinations as established in the SEED guidelines), a cap, nitrile gloves and face shield or safety glasses (reusable) and shoe covers. The examinations will be performed by endoscopist-guided sedation in accordance with current clinical guidelines.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasonography cohort</arm_group_label>
    <description>Abdominal ultrasound: They will be carried out according to international clinical guidelines (12). The explorer will wear an FFP2 mask, exceptionally a surgical mask, a gown, a hat, nitrile gloves, and a face shield or safety glasses (reusable) and shoe covers. The gel bottle, transducer, and stretcher will be washed prior to each scan with low-level disinfectant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telephonic cohort</arm_group_label>
    <description>The patient will be telephonically contacted for a medical visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Telephonic medical visit</intervention_name>
    <description>The patient will receive a telephonic call passing a medical visit</description>
    <arm_group_label>Telephonic cohort</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gastrointestinal endoscopy</intervention_name>
    <description>Upper or lower GI endoscopy according to clinical practice and current guidelines</description>
    <arm_group_label>Endoscopic cohort</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Abdominal ultrasound</intervention_name>
    <description>Diagnostic abdominal ultrasound according to the current guidelines</description>
    <arm_group_label>Ultrasonography cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for an ambulatory endoscopy, an ambulatory abdominal ultrasound, or a&#xD;
        telephonic visit&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled for an ambulatory endoscopy, an ambulatory abdominal ultrasound, or&#xD;
             a telephonic visit Age younger than 18 years.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        Refusal to sign the informed consent Immunosuppression (steroid treatment with a dose of 20&#xD;
        mg or more of prednisone daily, azathioprine, cyclosporine, mercaptopurine, methotrexate,&#xD;
        mycophenolate, tacrolimus, everolimus, chemotherapeutic agents, anti-tumoral necrosis&#xD;
        factor (TNF)-α drugs or other biological treatments for inflammatory bowel disease)&#xD;
        Immunodeficiency due to a non-pharmacological cause (HIV, hematological dyscrasias, primary&#xD;
        immunodeficiencies ...) Previous confirmed diagnosis (by PCR or serology) of SARS-CoV-2&#xD;
        disease. Diagnosis of previous suspicion (documented in the medical history by a physician)&#xD;
        of SARS-CoV-2 disease.&#xD;
&#xD;
        Previous clinical picture compatible with SARS-CoV-2 in the previous 2 months (defined as&#xD;
        any positive response to the check-list questionnaire contained in Annex III) Cognitive&#xD;
        impairment or hearing impairment preventing the phone visit Habitual residence outside the&#xD;
        province of Valladolid Ultrasound interventionism (liver biopsy, ultrasound-guided&#xD;
        paracentesis, biliary drainage ...)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Rio Hortega</name>
      <address>
        <city>Valladolid</city>
        <zip>47012</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Sociedad Espanola de Patologia Digestiva; Asociacion Espanola de Gastroenterologia. Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18). Rev Esp Enferm Dig. 2020 Apr;112(4):319-322. doi: 10.17235/reed.2020.7052/2020.</citation>
    <PMID>32202911</PMID>
  </reference>
  <reference>
    <citation>Huh S. How to train health personnel to protect themselves from SARS-CoV-2 (novel coronavirus) infection when caring for a patient or suspected case. J Educ Eval Health Prof. 2020 Jan;17:10. doi: 10.3352/jeehp.2020.17.10. Epub 2020 Mar 7. No abstract available.</citation>
    <PMID>32150796</PMID>
  </reference>
  <reference>
    <citation>Liu Z, Zhang Y, Wang X, Zhang D, Diao D, Chandramohan K, Booth CM. Recommendations for Surgery During the Novel Coronavirus (COVID-19) Epidemic. Indian J Surg. 2020 Apr;82(2):124-128. doi: 10.1007/s12262-020-02173-3. Epub 2020 Apr 11.</citation>
    <PMID>32292252</PMID>
  </reference>
  <reference>
    <citation>The Lancet. COVID-19: protecting health-care workers. Lancet. 2020 Mar 21;395(10228):922. doi: 10.1016/S0140-6736(20)30644-9. No abstract available.</citation>
    <PMID>32199474</PMID>
  </reference>
  <reference>
    <citation>Hunter E, Price DA, Murphy E, van der Loeff IS, Baker KF, Lendrem D, Lendrem C, Schmid ML, Pareja-Cebrian L, Welch A, Payne BAI, Duncan CJA. First experience of COVID-19 screening of health-care workers in England. Lancet. 2020 May 2;395(10234):e77-e78. doi: 10.1016/S0140-6736(20)30970-3. Epub 2020 Apr 22. No abstract available.</citation>
    <PMID>32333843</PMID>
  </reference>
  <reference>
    <citation>Chow EJ, Schwartz NG, Tobolowsky FA, Zacks RLT, Huntington-Frazier M, Reddy SC, Rao AK. Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington. JAMA. 2020 May 26;323(20):2087-2089. doi: 10.1001/jama.2020.6637.</citation>
    <PMID>32301962</PMID>
  </reference>
  <reference>
    <citation>Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020 Mar;25(10):2000180. doi: 10.2807/1560-7917.ES.2020.25.10.2000180. Erratum In: Euro Surveill. 2020 Jun;25(22):</citation>
    <PMID>32183930</PMID>
  </reference>
  <reference>
    <citation>Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung SM, Hayashi K, Kinoshita R, Yang Y, Yuan B, Akhmetzhanov AR, Linton NM. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis. 2020 May;94:154-155. doi: 10.1016/j.ijid.2020.03.020. Epub 2020 Mar 14. No abstract available.</citation>
    <PMID>32179137</PMID>
  </reference>
  <reference>
    <citation>Day M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ. 2020 Mar 23;368:m1165. doi: 10.1136/bmj.m1165. No abstract available.</citation>
    <PMID>32205334</PMID>
  </reference>
  <reference>
    <citation>van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17. No abstract available.</citation>
    <PMID>32182409</PMID>
  </reference>
  <reference>
    <citation>World Federation for Ultrasound in Medicine and Biology Safety Committee (Jacques S. Abramowicz, Iwaki Akiyama, David Evans, J. Brian Fowlkes, Karel Marsal, Yusef Sayeed and Gail ter Haar); Abramowicz JS, Basseal JM. World Federation for Ultrasound in Medicine and Biology Position Statement: How to Perform a Safe Ultrasound Examination and Clean Equipment in the Context of COVID-19. Ultrasound Med Biol. 2020 Jul;46(7):1821-1826. doi: 10.1016/j.ultrasmedbio.2020.03.033. Epub 2020 Apr 4. No abstract available.</citation>
    <PMID>32327199</PMID>
  </reference>
  <reference>
    <citation>Repici A, Aragona G, Cengia G, Cantu P, Spadaccini M, Maselli R, Carrara S, Anderloni A, Fugazza A, Pace F, Rosch T; ITALIAN GI-COVID19 Working Group. Low risk of COVID-19 transmission in GI endoscopy. Gut. 2020 Nov;69(11):1925-1927. doi: 10.1136/gutjnl-2020-321341. Epub 2020 Apr 22. No abstract available.</citation>
    <PMID>32321857</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 21, 2020</study_first_submitted>
  <study_first_submitted_qc>May 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2020</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital del Río Hortega</investigator_affiliation>
    <investigator_full_name>Marina de Benito Sanz</investigator_full_name>
    <investigator_title>Principal co-investigator</investigator_title>
  </responsible_party>
  <keyword>COVID</keyword>
  <keyword>SARS-CoV 2</keyword>
  <keyword>Endoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 6, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/33/NCT04401033/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT04401033
org study id: 003
nct id: NCT04401033
lead sponsor: 
has dmc: No
is fda regulated drug: No
is fda regulated device: No
The aim of our study to compare the proportion of patients who develop SARS-CoV-2 disease in
      3 groups: patients undergoing a abdominal ultrasound examination in a Specialty Center,
      patients undergoing endoscopic procedure in a third level hospital with CoronaVirus Disease
      (COVID-19) hospitalization plants and patients who make a telephonic visit (do not go to the
      hospital) in the digestive system service.
Patients will undergo a telephonic interview 48-96h before the procedure where will ask about
      the presence of symptoms suggestive of SARS-CoV-2 infection. Optionally, they will also be
      carried out a scan (PCR) to detect infection 48-96h before procedure, withdrawing from the
      study patients with positive PCR or infection suspected by clinical data according to the
      questionnaire, after evaluating the responses to the questionnaire by one of the members of
      the research team.

      Endoscopic examinations will be carried out according to the recommendations of the Spanish
      Society for Digestive Endoscopy (SEED). The patient will perform a hand wash with solution
      hydroalcoholic before entering the endoscopy room, and you will be placed a surgical mask and
      gloves. Staff close to the patient will carry FFP2 mask, exceptionally surgical mask, gown
      (waterproof in high-risk examinations as established in the SEED guidelines), hat, nitrile
      gloves and face shield or safety glasses (reusable) and shim covers. The examinations will be
      carried out using sedation guided by endoscopist according to current clinical guidelines.

      Ultrasonographic examinations (US) will be carried out according to clinical guideline. The
      examinator will wear a filtering face pieces 2 (FFP2) mask, exceptionally surgical mask,
      gown, cap, nitrile gloves and face shield or goggles safety (reusable) and shoe covers. The
      gel bottle, the transducer and the gurney will be washed before each US with low level
      disinfectant.

      Patients who meet the inclusion criteria and do not have any exclusion criteria will be
      invited to participate in the study. The patients who agree to participate will complete the
      informed consent according to the law 41/2002 of patient autonomy without for that reason
      alter the relationship with your doctor or cause any harm to your treatment. The monitoring
      period will have a maximum duration of 17 days. It will consist of a telephone control
      through a pre-established checklist. In case of any positive answer to the questionnaire, it
      will be completed the study through the consultation of the investigators by means of a
      polymerase chain reaction (PCR).
observational model: Cohort
time perspective: Prospective
measure: SARS-CoV-2 infection in patients
time frame: may-june 2020
description: Proportion of patients who develop SARS-CoV-2 infection in 3 groups: patients undergoing an abdominal ultrasound examination in a Specialty Center, patients undergoing an endoscopic examination in a third-level hospital with hospitalization facilities COVID-19 and patients who make a non-face-to-face consultation (do not go to the hospital) in the digestive system service
measure: SARS-CoV-2 infection in HCW
time frame: may-june 2020
description: Number of Health Care Workers (HCW) who develop SARS-CoV-2 infection in endoscopy service in this period
arm group label: Endoscopic cohort
description: Endoscopic examinations: They will be carried out according to the recommendations of the Spanish society for digestive endoscopy (SEED). In summary, the patient will perform a hand wash with hydroalcoholic solution before entering the endoscopy room, and will put on a surgical mask and gloves. Personnel close to the patient will wear an FFP2 mask, exceptionally a surgical mask, a gown (waterproof in high-risk examinations as established in the SEED guidelines), a cap, nitrile gloves and face shield or safety glasses (reusable) and shoe covers. The examinations will be performed by endoscopist-guided sedation in accordance with current clinical guidelines.
arm group label: Ultrasonography cohort
description: Abdominal ultrasound: They will be carried out according to international clinical guidelines (12). The explorer will wear an FFP2 mask, exceptionally a surgical mask, a gown, a hat, nitrile gloves, and a face shield or safety glasses (reusable) and shoe covers. The gel bottle, transducer, and stretcher will be washed prior to each scan with low-level disinfectant
arm group label: Telephonic cohort
description: The patient will be telephonically contacted for a medical visit.
intervention type: Behavioral
intervention name: Telephonic medical visit
description: The patient will receive a telephonic call passing a medical visit
arm group label: Telephonic cohort
intervention type: Procedure
intervention name: Gastrointestinal endoscopy
description: Upper or lower GI endoscopy according to clinical practice and current guidelines
arm group label: Endoscopic cohort
intervention type: Procedure
intervention name: Abdominal ultrasound
description: Diagnostic abdominal ultrasound according to the current guidelines
arm group label: Ultrasonography cohort
study pop: 
sampling method: Non-Probability Sample
criteria: 
gender: All
minimum age: 18 Years
maximum age: N/A
healthy volunteers: No
facility: 
country: Spain
citation: Sociedad Espanola de Patologia Digestiva; Asociacion Espanola de Gastroenterologia. Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18). Rev Esp Enferm Dig. 2020 Apr;112(4):319-322. doi: 10.17235/reed.2020.7052/2020.
PMID: 32202911
citation: Huh S. How to train health personnel to protect themselves from SARS-CoV-2 (novel coronavirus) infection when caring for a patient or suspected case. J Educ Eval Health Prof. 2020 Jan;17:10. doi: 10.3352/jeehp.2020.17.10. Epub 2020 Mar 7. No abstract available.
PMID: 32150796
citation: Liu Z, Zhang Y, Wang X, Zhang D, Diao D, Chandramohan K, Booth CM. Recommendations for Surgery During the Novel Coronavirus (COVID-19) Epidemic. Indian J Surg. 2020 Apr;82(2):124-128. doi: 10.1007/s12262-020-02173-3. Epub 2020 Apr 11.
PMID: 32292252
citation: The Lancet. COVID-19: protecting health-care workers. Lancet. 2020 Mar 21;395(10228):922. doi: 10.1016/S0140-6736(20)30644-9. No abstract available.
PMID: 32199474
citation: Hunter E, Price DA, Murphy E, van der Loeff IS, Baker KF, Lendrem D, Lendrem C, Schmid ML, Pareja-Cebrian L, Welch A, Payne BAI, Duncan CJA. First experience of COVID-19 screening of health-care workers in England. Lancet. 2020 May 2;395(10234):e77-e78. doi: 10.1016/S0140-6736(20)30970-3. Epub 2020 Apr 22. No abstract available.
PMID: 32333843
citation: Chow EJ, Schwartz NG, Tobolowsky FA, Zacks RLT, Huntington-Frazier M, Reddy SC, Rao AK. Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington. JAMA. 2020 May 26;323(20):2087-2089. doi: 10.1001/jama.2020.6637.
PMID: 32301962
citation: Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020 Mar;25(10):2000180. doi: 10.2807/1560-7917.ES.2020.25.10.2000180. Erratum In: Euro Surveill. 2020 Jun;25(22):
PMID: 32183930
citation: Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung SM, Hayashi K, Kinoshita R, Yang Y, Yuan B, Akhmetzhanov AR, Linton NM. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis. 2020 May;94:154-155. doi: 10.1016/j.ijid.2020.03.020. Epub 2020 Mar 14. No abstract available.
PMID: 32179137
citation: Day M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ. 2020 Mar 23;368:m1165. doi: 10.1136/bmj.m1165. No abstract available.
PMID: 32205334
citation: van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17. No abstract available.
PMID: 32182409
citation: World Federation for Ultrasound in Medicine and Biology Safety Committee (Jacques S. Abramowicz, Iwaki Akiyama, David Evans, J. Brian Fowlkes, Karel Marsal, Yusef Sayeed and Gail ter Haar); Abramowicz JS, Basseal JM. World Federation for Ultrasound in Medicine and Biology Position Statement: How to Perform a Safe Ultrasound Examination and Clean Equipment in the Context of COVID-19. Ultrasound Med Biol. 2020 Jul;46(7):1821-1826. doi: 10.1016/j.ultrasmedbio.2020.03.033. Epub 2020 Apr 4. No abstract available.
PMID: 32327199
citation: Repici A, Aragona G, Cengia G, Cantu P, Spadaccini M, Maselli R, Carrara S, Anderloni A, Fugazza A, Pace F, Rosch T; ITALIAN GI-COVID19 Working Group. Low risk of COVID-19 transmission in GI endoscopy. Gut. 2020 Nov;69(11):1925-1927. doi: 10.1136/gutjnl-2020-321341. Epub 2020 Apr 22. No abstract available.
PMID: 32321857
responsible party type: Principal Investigator
investigator affiliation: Hospital del Río Hortega
investigator full name: Marina de Benito Sanz
investigator title: Principal co-investigator
mesh term: Infections
mesh term: Coronavirus Infections
sharing ipd: Undecided
provided document: 